Take a look on data: Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT)

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) above +14.33% and ended at $+1.36. The stock’s market capitalization arrived at $142.339M and total traded volume was 298,908 shares. The stock has a 52-week highest price of $10.29 and its 52-week lowest price was called at $4.11. During last trade, its maximum trading price was registered $11.44 and it’s the minimum trading price was noted $9.46.

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), recently stated its financial results for the quarter ended March 31, 2019 and provided a corporate update.

Financial Results for the Quarter Ended March 31, 2019

Revenues in conjunction with planned alliances and collaborations: Alliance revenue was $4.4M during the three months ended March 31, 2019, contrast to $2.4M in the three months ended March 31, 2018.

Operating expenses: Operating expenses were $10.9M in the three months ended March 31, 2019, a raise of about 20% contrast to $9.0M in the three months ended March 31, 2018.

Net Loss: Net loss for the three months ended March 31, 2019 was about $6.9M, or ($0.68) per basic and diluted share, contrast with a net loss of $6.6M, or ($0.66) per basic and diluted share, in the three-month period ended March 31, 2018.

Cash: At March 31, 2019, Arcturus had cash and cash equivalents totaling $31.2M, contrast to cash, cash equivalents of $36.7M at December 31, 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *